featured
Tocilizumab Improves Inflammation in Patients With Non-STEMI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of a Single Dose of the Interleukin-6 Receptor Antagonist Tocilizumab on Inflammation and Troponin T Release in Patients With Non-ST-Elevation Myocardial Infarction: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Eur Heart J 2016 May 08;[EPub Ahead of Print], O Kleveland, G Kunszt, M Bratlie, T Ueland, K Broch, E Holte, AE Michelsen, B Bendz, BH Amundsen, T Espevik, S Aakhus, JK Damås, P Aukrust, R Wiseth, L GullestadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.